The effects of land use disturbance varies with trophic position in littoral cichlid fish communities from Lake Tanganyika

Impacts of anthropogenic disturbance are especially severe in freshwater ecosystems. In particular, land use disturbance can lead to increased levels of pollution, including elevated nutrient and sediment loads whose negative impacts range from the community to the individual level. However, few studies have investigated if these impacts are uniform across species represented by multiple trophic levels. To address this knowledge gap, we focused on Lake Tanganyika cichlid fishes, which comprise hundreds of species representing a wide range of feeding strategies. Cichlids are at their most diverse within the near‐shore environment; however, land use disturbance of this environment has led to decreasing diversity, particularly in herbivores. We therefore tested if there is a uniform effect of pollution across species and trophic groups within the hyper‐diverse rocky shore cichlid fish community. We selected three sites with differing levels of human impact along the Tanzanian coastline and 10 cichlid species, comprising varying taxonomic and trophic groups, common to these sites. Nitrogen and carbon stable isotope values for 528 samples were generated and analysed using generalised linear mixed models. We also estimated stomach contents including sediment proportions. Our study highlights that multiple sources of pollution are having differing effects across species within a diverse fish community. We found that nitrogen stable isotope values were significantly higher at the most disturbed (urbanised) site for benthic feeding species, whereas there was no difference in these isotopes between sites for the water column feeding trophic group. Stomach contents revealed that the elevated δ15N values were unlikely to have been caused by differences in diet between sites. However, at the most disturbed site, higher proportions of sediment were present in most herbivores, irrespective of foraging behaviour. It is likely that anthropogenic nitrogen loading is the cause of higher nitrogen stable isotope values since there was no evidence of species shifting trophic levels between sites. Results support our previous study showing herbivore species to be most affected by human disturbance and make the link to pollution much more explicit. As lower diversity of consumers can negatively affect ecosystem processes such as stability, alleviating environmental impact through sewage treatment and afforestation programmes should continue to be a global priority for the conservation of aquatic ecosystems, as well as human health

Molecular and cellular mechanisms underlying the evolution of form and function in the amniote jaw.

The amniote jaw complex is a remarkable amalgamation of derivatives from distinct embryonic cell lineages. During development, the cells in these lineages experience concerted movements, migrations, and signaling interactions that take them from their initial origins to their final destinations and imbue their derivatives with aspects of form including their axial orientation, anatomical identity, size, and shape. Perturbations along the way can produce defects and disease, but also generate the variation necessary for jaw evolution and adaptation. We focus on molecular and cellular mechanisms that regulate form in the amniote jaw complex, and that enable structural and functional integration. Special emphasis is placed on the role of cranial neural crest mesenchyme (NCM) during the species-specific patterning of bone, cartilage, tendon, muscle, and other jaw tissues. We also address the effects of biomechanical forces during jaw development and discuss ways in which certain molecular and cellular responses add adaptive and evolutionary plasticity to jaw morphology. Overall, we highlight how variation in molecular and cellular programs can promote the phenomenal diversity and functional morphology achieved during amniote jaw evolution or lead to the range of jaw defects and disease that affect the human condition

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.

BACKGROUNDS & AIMS Primary biliary cholangitis (PBC) is a chronic liver disease in which autoimmune destruction of the small intrahepatic bile ducts eventually leads to cirrhosis. Many patients have inadequate response to licensed medications, motivating the search for novel therapies. Previous genome-wide association studies (GWAS) and meta-analyses (GWMA) of PBC have identified numerous risk loci for this condition, providing insight into its aetiology. We undertook the largest GWMA of PBC to date, aiming to identify additional risk loci and prioritise candidate genes for in silico drug efficacy screening. METHODS We combined new and existing genotype data for 10,516 cases and 20,772 controls from 5 European and 2 East Asian cohorts. RESULTS We identified 56 genome-wide significant loci (20 novel) including 46 in European, 13 in Asian, and 41 in combined cohorts; and a 57 genome-wide significant locus (also novel) in conditional analysis of the European cohorts. Candidate genes at newly identified loci include FCRL3, INAVA, PRDM1, IRF7, CCR6, CD226, and IL12RB1, which each play key roles in immunity. Pathway analysis reiterated the likely importance of pattern recognition receptor and TNF signalling, JAK-STAT signalling, and differentiation of T helper (T)1 and T17 cells in the pathogenesis of this disease. Drug efficacy screening identified several medications predicted to be therapeutic in PBC, some of which are well-established in the treatment of other autoimmune disorders. CONCLUSIONS This study has identified additional risk loci for PBC, provided a hierarchy of agents that could be trialled in this condition, and emphasised the value of genetic and genomic approaches to drug discovery in complex disorders. LAY SUMMARY Primary biliary cholangitis (PBC) is a chronic liver disease that eventually leads to cirrhosis. In this study, we analysed genetic information from 10,516 people with PBC and 20,772 healthy individuals recruited in Canada, China, Italy, Japan, the UK, or the USA. We identified several genetic regions associated with PBC. Each of these regions contains several genes. For each region, we used diverse sources of evidence to help us choose the gene most likely to be involved in causing PBC. We used these 'candidate genes' to help us identify medications that are currently used for treatment of other conditions, which might also be useful for treatment of PBC